PMID- 19379847 OWN - NLM STAT- MEDLINE DCOM- 20091102 LR - 20111117 IS - 1878-0849 (Electronic) IS - 1769-7212 (Linking) VI - 52 IP - 4 DP - 2009 Jul-Aug TI - Characterization of a de novo balanced translocation in a patient with moderate mental retardation and dysmorphic features. PG - 211-7 LID - 10.1016/j.ejmg.2009.04.002 [doi] AB - Moderate mental retardation (MR) could affect up to 3% of the general population. A proportion of these cases has a genetic origin. Genes responsible for mental retardation can be identified taking advantage of familial cases or patients carrying a chromosomal rearrangement. We have studied a female patient with mild mental retardation and dysmorphic features. Cytogenetic and molecular investigations revealed a de novo balanced translocation 46, XX, t(5;18)(q21.3;q21.32) in the patient. The karyotypes of the parents are normal. We mapped the breakpoints of the translocation on chromosomes 5 and 18 by fluorescence in situ hybridization (FISH). The characterization of the chromosomal breakpoints helped us identify a new candidate region containing a portion of a gene. This gene is called FER. It is a tyrosine kinase located on the chromosome 5q21.3. We found no known genes in the genomic region corresponding to the BAC spanning the 18q21.32 breakpoint. Molecular analysis showed that the FER gene was not interrupted by the translocation breakpoint on chromosome 5. Real-time quantitative PCR performed using RNA from the patient, compared to her parents and controls, showed no significant modification of FER expression ruling out a putative position effect, at least in the tissue tested. Our data suggest that FER is not implicated in the mental retardation phenotype observed in the reported patient. Therefore the MR phenotype might not be caused by the translocation. FAU - Haddad, Marie-Reine AU - Haddad MR AD - INSERM U910, faculte de medecine de la Timone, Marseille, France. FAU - Mignon-Ravix, Cecile AU - Mignon-Ravix C FAU - Cacciagli, Pierre AU - Cacciagli P FAU - Megarbane, Andre AU - Megarbane A FAU - Villard, Laurent AU - Villard L LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090418 PL - Netherlands TA - Eur J Med Genet JT - European journal of medical genetics JID - 101247089 RN - 110736-90-8 (proto-oncogene protein c-fes-fps) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) SB - IM MH - Base Sequence MH - Chromosome Aberrations MH - Chromosome Breakage MH - Chromosome Painting MH - Chromosomes, Artificial, Bacterial MH - *Chromosomes, Human, Pair 18 MH - *Chromosomes, Human, Pair 5 MH - Comparative Genomic Hybridization MH - Consanguinity MH - Face/*abnormalities MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Intellectual Disability/*genetics MH - Karyotyping MH - Molecular Sequence Data MH - Physical Chromosome Mapping MH - Protein-Tyrosine Kinases/genetics MH - *Translocation, Genetic EDAT- 2009/04/22 09:00 MHDA- 2009/11/03 06:00 CRDT- 2009/04/22 09:00 PHST- 2008/08/18 00:00 [received] PHST- 2009/04/02 00:00 [accepted] PHST- 2009/04/22 09:00 [entrez] PHST- 2009/04/22 09:00 [pubmed] PHST- 2009/11/03 06:00 [medline] AID - S1769-7212(09)00037-8 [pii] AID - 10.1016/j.ejmg.2009.04.002 [doi] PST - ppublish SO - Eur J Med Genet. 2009 Jul-Aug;52(4):211-7. doi: 10.1016/j.ejmg.2009.04.002. Epub 2009 Apr 18.